Pittsburgh woman gets probation for her role in painkiller scheme |

Pittsburgh woman gets probation for her role in painkiller scheme

OxyContin, an opioid painkiller.

A federal judge on Wednesday sentenced a 66-year-old Pittsburgh woman to probation for her part in a prescription drug ring that involved more than a dozen people, officials said.

Angela Vernon of the city’s Bedford Dwellings section was sentenced to three years of probation for her conviction on charges of health care fraud and conspiracy to distribute Oxycodone and Oxymorphone, according to a release from U.S. Attorney Scott Brady’s office.

Vernon was charged in December 2016 in a bust that netted 17 others. Those involved got prescriptions for addictive painkillers under the guise they needed the medication themselves, according to the release. Then they turned around and sold the medication to others suffering from painkiller addiction.

The painkillers were often paid for through government-funded health insurance programs, making taxpayers foot the bill for the drug ring.

Megan Guza is a Tribune-Review staff writer.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.